Infectious Diseases (except HIV/AIDS)
Showing page 320 of 716 pages of list content
-
Neutralizing antibody responses to SARS-CoV-2 variants in vaccinated Ontario long-term care home residents and workers
This article's authors -
Molecular and serological investigation of the 2021 COVID-19 case surge in Mongolian vaccinees
This article's authors -
T cell responses to SARS-CoV-2 in people with and without neurologic symptoms of long COVID
This article's authors -
Evaluation of the Liberty16 mobile real time PCR device for use with the SalivaDirect assay for SARS-CoV-2 testing
This article's authors -
DECREASED BREADTH OF THE ANTIBODY RESPONSE TO THE SPIKE PROTEIN OF SARS-CoV-2 AFTER REPEATED VACCINATION
This article's authors -
Durability and Cross-Reactivity of Immune Responses Induced by an AS03-Adjuvanted Plant-Based Recombinant Virus-Like Particle Vaccine for COVID-19
This article's authors -
Efficacy and Safety of Ayurveda Intervention (AYUSH 64) as add-on therapy for patients with COVID-19 infections â An open labelled, Parallel Group, Randomized controlled clinical trial
This article's authors -
Clinical features, demography and predictors of outcomes of SARS-CoV-2 infection in a tertiary care hospital in India-A cohort study
This article's authors -
Immunogenicity of BNT162b2 vaccine Against the Alpha and Delta Variants in Immunocompromised Patients
This article's authors -
A booster dose is immunogenic and will be needed for older adults who have completed two doses vaccination with CoronaVac: a randomised, double-blind, placebo-controlled, phase 1/2 clinical trial
This article's authors